Lab
Laboratorio Clinico Y De Referencia De Fajardo, INC.
Laboratorio Clinico Y De Referencia De Fajardo, INC. was paid $76K by Medicaid between Dec 2021 and Dec 2024, across 36 billing codes. Its largest line is 85025, Blood count; complete (CBC), automated, and automated differential WBC count — 13% of everything it billed.
33Billing provider infoLABORATORIO CLINICO Y DE REFERENCIA DE FAJARDO, INC.
VIEQUES, PR 00765
VIEQUES, PR 00765
33aNPI1063636546assigned 04/13/2007
33bProvider typeClinical Medical Laboratory
28Total paid$76K
24GClaims11,586
24DCodes billed36
24AFirst – last monthDec 2021 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#571 of 777
Median peer was paid$278K
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 14 | $325.00 | |
| 2022 | 53 | $1K | |
| 2024incomplete | 11,519 | $74K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 13% | 1,904 | 1,636 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 13% | 607 | 311 | $10K |
| 84443 | Thyroid stimulating hormone (TSH) | 12% | 1,046 | 935 | $9K |
| 80061 | Lipid panel | 9.1% | 1,031 | 934 | $7K |
| 80053 | Comprehensive metabolic panel | 9.1% | 1,213 | 1,091 | $7K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 5.5% | 119 | 112 | $4K |
| 86738 | 4.8% | 334 | 298 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.7% | 117 | 106 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.7% | 116 | 105 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.5% | 405 | 350 | $3K |
| 84439 | 3.5% | 521 | 473 | $3K | |
| 82274 | 3.4% | 241 | 224 | $3K |
24 more codes
| 81001 | 3.2% | 1,322 | $2K | |
| 80074 | 2.8% | 51 | $2K | |
| 86703 | 1.5% | 122 | $1K | |
| 84153 | 1.4% | 117 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 100 | $686.85 |
| 85027 | <1% | 127 | $653.55 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 27 | $650.00 |
| 84479 | <1% | 290 | $569.36 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 13 | $530.36 |
| 85730 | <1% | 90 | $463.26 | |
| 86592 | <1% | 151 | $444.67 | |
| 85610 | <1% | 90 | $328.90 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 448 | $314.81 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 39 | $296.00 |
| 87276 | <1% | 13 | $160.70 | |
| 87275 | <1% | 13 | $122.50 | |
| 85651 | <1% | 52 | $118.49 | |
| 84703 | <1% | 14 | $82.72 | |
| 86701 | <1% | 12 | $68.90 | |
| 86140 | <1% | 13 | $51.80 | |
| 82570 | <1% | 165 | $30.84 | |
| 82043 | <1% | 206 | $28.63 | |
| 3061F | 0% | 154 | $0.00 | |
| 3044F | 0% | 303 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTORRES, SEVERINO (DIRECTOR)
Parent organizationLABORATORIO CLINICO Y DE REFERENCIA DE FAJARDO, INC